 2-Adrenoceptor Antagonist SL84.0418 Involvement in the Development of Opioid Withdrawal

E-ISSN： 1875-628x|6|2|159-162

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.6, Iss.2, 2009-03, pp. : 159-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antagonist Treatment of Opioid Withdrawal Translational Low Dose Approach

By Mannelli Paolo Gottheil Edward Van Bockstaele Elisabeth J.

Journal of Addictive Diseases, Vol. 25, Iss. 2, 2006-06 ,pp. : 1-8

Haworth Press

Access to resources Recommend Favorite

Assessment of 2 -adrenoceptor antagonist potency with GTPase assay

By Virolainen S. Jansson C.C. Scheinin M.

European Journal of Pharmacology, Vol. 338, Iss. 3, 1997-11 ,pp. : 293-296

Elsevier

Access to resources Recommend Favorite

Alpha-2 Adrenoceptor Ligands and Opioid Drugs: Pharmacological Interactions of Therapeutic Interest

Current Neuropharmacology, Vol. 2, Iss. 4, 2004-10 ,pp. : 343-352

Bentham Science Publishers

Access to resources Recommend Favorite

1 - and 2 -Adrenoceptor antagonist activity of a series of para-substituted N-isopropylphenoxypropanolamines

By Louis S.N. Nero T.L. Iakovidis D. Colagrande F.M. Jackman G.P. Louis W.J.

European Journal of Medicinal Chemistry, Vol. 34, Iss. 11, 1999-11 ,pp. : 919-937

Elsevier

Access to resources Recommend Favorite

Facilitation of cognitive functions by a specific 2 -adrenoceptor antagonist, atipamezole

By Haapalinna A. Sirvio J. Lammintausta R.

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 29-40

Elsevier

Access to resources Recommend Favorite